Introduction {#s0001}
============

Ageing is a primary risk factor for atherosclerosis and cardiovascular diseases (North & Sinclair [@CIT0029]). Cardiac ageing is characterised by prominent changes in cardiovascular tissues including hypertrophy, altered left ventricular (LV) diastolic function and cardiac output (CO), and increased arterial stiffness. In older adults, resting CO is preserved by an increase in LV end-diastolic volume with a consequent augmentation of stroke volume (SV). With the increase in energy demands during exercise, older adults achieve people a higher SV and mean arterial blood pressure (BP) but lower heart rate (HR) and peak oxygen consumption compared to younger subjects. Therefore, SV during exercise in older adults is preserved by an increase in end-diastolic volume, whereas in younger subjects is maintained by a progressive decrease in end-systolic volume (Cheitlin [@CIT0005]; Houghton et al. [@CIT0015]). Augmentation index (AIx) was significantly higher in older than younger participants and was inversely related to CO in older participants (Houghton et al. [@CIT0015]).

Nitric oxide (NO) appears to have pleiotropic effects on cardiac physiology (North & Sinclair [@CIT0029]), being produced by all myocardial cells and is involved in the regulation of coronary vasodilation and cardiomyocyte contractility (Massion et al. [@CIT0026]). NO is synthesised by vascular and endocardial endothelial nitric oxide synthases (NOS), as well as neuronal and inducible NOS (Rastaldo et al. [@CIT0033]). The effects of NO on myocardial contractility appear to be mediated by the opening of sarcolemmal voltage-operated and sarcoplasmic ryanodine receptor Ca(2+) channels (Rastaldo et al. [@CIT0033]). NO is also involved in the modulating post-ischaemic cardiac remodelling infarction which may be mediated by a decreased mitochondrial permeability (Di Lisa et al. [@CIT0010]).

NO is involved in several other physiological functions such as maintenance of vascular tone, platelet adhesion, angiogenesis, mitochondrial oxygen consumption, muscular performance and control of immunity and inflammation signalling pathways (Kelm [@CIT0019]). Inorganic  NO~3~ ^-^ represents the final, stable end product of NO metabolism and it is mainly excreted in urine (∼70%). Approximately 25--30% of circulating blood  NO~3~ ^-^ enters a non-enzymatic NO synthetic pathway involving salivary glands, oral microbiota and gastric acidic environment (Lundberg et al. [@CIT0025]). Inorganic  NO~3~ ^-^ from food can also enter the non-enzymatic NO pathway, increase NO production and induce positive effects on cardiovascular function and muscle performance (Lundberg et al. [@CIT0025]). The role of ageing as a modifier of the effects of inorganic  NO~3~ ^-^ on cardiovascular outcomes remains unknown. Convincing evidence on health benefits of dietary  NO~3~ ^-^ on cardiovascular outcomes currently exists for young- and middle-aged individuals (Lara, Ashor, et al. [@CIT0012]; Gee & Ahluwalia [@CIT0012]), whereas contrasting findings have been reported in older populations (Siervo et al. [@CIT0035]; Lara, Ogbonmwan, et al. [@CIT0013]; Gee & Ahluwalia [@CIT0012]; Omar et al. [@CIT0030]). In addition, limited information is available on the effects of inorganic  NO~3~ ^-^ consumption on cardiac function at rest and during exercise in healthy adults (DeVan et al. [@CIT0009]; Lee et al. [@CIT0024]) and in patients with heart disease (Zamani et al. [@CIT0037]; Eggebeen et al. [@CIT0011]).

We hypothesise that dietary NO~3~ ^-^ consumption can increase systemic NO bio-availability and have a positive effect on central and peripheral haemodynamic responses of healthy older adults measured at rest, during different exercise intensities (low, moderate and high) and post-exercise recovery. We evaluated the effects of beetroot juice, chosen as a rich source of dietary NO~3~ ^-^, on BP, AIx and haemodynamic parameters of cardiac function including CO, SV, cardiac index (CI) and HR measured at rest and during graded exercise on a stationary bike. We also evaluated whether dietary NO~3~ ^-^ consumption induced changes in circulating biomarkers of inflammation, oxidative stress and endothelial integrity to provide mechanistic insights into the effects of dietary NO~3~ ^-^ on circulatory biomarkers closely involved in the regulation of vascular function.

Methods {#s0002}
=======

The trial was approved by the North of Scotland Research Ethics committee (14/NS/0061) and conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants. The study was a double-blind, cross-over, placebo-controlled RCT which took place between May and August 2014 across two sites (Newcastle upon Tyne and Sheffield). The duration of the each intervention was 1 week with a wash-out period between treatments of at least 1 week. This trial was registered in the International Standard Randomised Controlled Trial Number Register (ISRCTN19064955).

Participants {#s0003}
------------

Twenty older healthy people (10 males, 10 females) were recruited (10 participants per site). Participants were included in the study if they did not have medical conditions or were not taking medications that might influence the study outcomes. A full list of the inclusion and exclusion criteria is provided in the [Online Supplementary Material](http://dx.doi.org/10.1080/09637486.2017.1328666). Participants were asked to maintain their habitual diet and to avoid using chewing gum or mouth wash for at least 48 h prior to the baseline visits (first and third visit) and during each of the 1-week supplementation periods.

Study overview {#s0004}
--------------

A telephone screening was performed to check eligibility to the trial's inclusion and exclusion criteria. Eligible participants were asked to arrive at the research facilities after a 12-h overnight fast and having avoided strenuous physical activity for 3 d preceding the visit. Eligibility to the study was confirmed by measuring BMI, resting BP and conducting a resting 12 lead electrocardiogram. Participants were randomised to a cross-over intervention and the assessment continued with the measurement of body composition and collection of blood and urine samples and the assessment of physical capability (reported elsewhere). Participants then rested for 1 h and consumed a meal providing approximately 300 kcal (CHO = 85%, PRO = 3%, FAT = 12%). After the 1-hur rest period, the exercise test was explained to the participants and they became accustomised to the bicycle ergometer. The exercise protocol is described in [Figure S1](http://dx.doi.org/10.1080/09637486.2017.1328666) of the Online Supplementary Material. After the vascular measurements and the exercise test, instructions were provided for self-administration of the nutritional intervention (14 bottles of either NO~3~ ^-^ -rich or NO~3~ ^-^ -depleted beetroot juice; 70 ml ×2/d; Beet It, James White Ltd, Ashbocking, Suffolk, UK) and asked to consume one bottle of beetroot juice each morning and evening for the subsequent 7 d. The daily dose of NO~3~ ^-^-rich (intervention) or NO~3~ ^-^ -depleted (placebo) beetroot juice contained ∼12 mmol and ∼0.003 mmol of NO~3~ ^-^, respectively. This concluded Visit 1 of the trial. Participants returned to the research facilities in the morning of day 8 after they had completed a 7-d supplementation period. Measurements were conducted approximately after 12 h from drinking the beetroot juice as participants were asked to fast overnight before arriving to the research centre. The resting 12 lead ECG was performed and if normal the visit continued with a repeat of the assessments performed at visit 1. At the end of the second visit, participants were asked to resume their habitual diet and physical activity. After a wash-out period of at least 7 d, the second phase (including Visits 3 and 4) was conducted similar to the first phase with the exception that participants crossed-over experimental arms, that is consumed the other intervention agent.

Resting and daily blood pressure {#s0005}
--------------------------------

Resting BP was measured in triplicate using an automated BP monitor (Omron M3, Omron Healthcare, Milton Keynes, UK) at each clinic visit with the participant seated comfortably for 15 min prior to the measurement and the arm supported at the level of the heart. The same BP monitor was provided to each participant for the measurements of daily resting BP at home. Participants were asked to conduct duplicate measurements in a seated position in the morning before drinking the juice and in the evening before going to bed. Agreement of the daily BP monitoring was verified against the BP recordings obtained from the 24-h Ambulatory Blood Pressure Monitoring (ABPM) (systolic BP, *r* = 0.71, *p* \< .001, *n* = 84; diastolic BP, *r* = 0.80, *p* \< .001, *n* = 84) (Jajja et al. [@CIT0016]).

Resting and exercise central haemodynamics {#s0006}
------------------------------------------

All subjects performed a maximal graded cardiopulmonary exercise test using an electro-magnetically controlled bicycle ergometer (Corival, Lode, Groningen, The Netherlands) with online gas exchange measurements (Metalyzer 3B, Cortex, Leipzig, Germany). The maximal progressive exercise test included cycling with 10-W increments every minute until volitional exhaustion. The 12-lead ECG (Custo, CustoMed GmbH, Ottobrunn, Germany) was continuously monitored and BP (Tango, SunTech Medical, Morrisville, NC) recorded at rest, during exercise and recovery (Newcastle Centre only, *N* = 10). The test was terminated when the subject was unable to pedal at a cadence of 50 rpm or they reached maximal oxygen consumption. Peak oxygen consumption was defined as the average oxygen uptake during the last minute of exercise. Non-invasive central haemodynamics parameters (SV, CO and CI) were measured by bioreactance method (NICOM, Cheetah Medical, Newton Center, MA) (Jakovljevic et al. [@CIT0017]). CO was estimated under resting and exercise stress testing conditions using the bio-reactance method which analysis the frequency of relative phase shifts of electrical current applied across the thorax using four dual-surface electrodes. Signals were applied to and recorded from the left and right sides of the thorax; these signals are processed separately and averaged after digital processing. The signal processing unit of the system determines the relative phase shift between the input signal relative to the output signal. The phase shift occurs due to instantaneous changes in blood flow in the aorta. CO is subsequently estimated as the product of SV and HR. CI is calculated by adjusting the CO for body surface area. A graphical description of the protocol is described in [Figure S2](http://dx.doi.org/10.1080/09637486.2017.1328666) of the Online Supplementary Material.

Augmentation index {#s0007}
------------------

A high fidelity micro-manometer was used to apply a gentle pressure and therefore flatten the radial artery in the non-dominant hand at the wrist under resting condition using the SphygmoCor (AtCor Medical, West Ryde, NSW, Australia). Central aortic pressure and AIx were then calculated automatically using the SphygmoCor software. AIx was calculated as the difference between the first systolic peak and the second systolic peak of the central arterial waveform, which was expressed as a percentage of pulse pressure.

Anthropometry, dietary and lifestyle questionnaires {#s0008}
---------------------------------------------------

Body weight and height were measured to the nearest 0.1 kg and 0.5 cm, respectively. The nine-item short form of the International Physical Activity Questionnaire (IPAQ) was used to record levels of physical activity: (1) vigorous-intensity activity, (2) moderate-intensity activity, (3) walking and (4) sitting. A combined total physical activity score was calculated and expressed in MET-min/week (Craig et al. [@CIT0008]). The EPIC Food Frequency Questionnaire (FFQ) was administered at baseline and the FETA software used to extract dietary (energy and nutrient) information (Mulligan et al. [@CIT0028]).

Blood and urine collection {#s0009}
--------------------------

Fasting blood samples were collected at the beginning of each visit and centrifuged at 3000 rpm for 10 min at 4 °C within 30 min of collection. Aliquots of plasma and serum were frozen and stored at −80 °C for subsequent analyses. Mid-stream urine samples were collected, in fasting conditions, into sterile containers and stored at −20 °C for subsequent analyses.

Biomarker analysis {#s0010}
------------------

A modified version of the gas chromatography/mass spectrometry (GC--MS) method proposed by Tsikas ([@CIT0036]) was used to determine NO~3~ ^-^ and NO~2~ ^-^ concentrations in urine and plasma samples and sum of NO~3~ ^-^ and NO~2~ ^-^ (NO*~x~*) was calculated. However, blood samples were not immediately processed (∼30--45 min) to preserve NO~2~ ^-^ and therefore NO~3~ ^-^ is the main contributor to the total concentration of NO*~x~*. The protocol and validation of the modified GC--MS method have been described elsewhere (Qadir et al. [@CIT0032]). Methods for the measurement of glucose, insulin, IL-6, 3-NT, cGMP, ET-1, P-selectin, E-Selectin, intercellular adhesion molecule-3 (ICAM-3) and thrombomodulin are reported in the [Online Supplementary Material](http://dx.doi.org/10.1080/09637486.2017.1328666).

Statistical analysis {#s0011}
--------------------

Repeated-measures general linear models were used to test the effect of NO~3~ ^-^ consumption on measures of vascular function and blood biomarkers. Treatment (nitrate vs. placebo) was entered as a group factor (Tr) and the time points of the incremental exercise test as the repeated factor (Ti). Post-hoc comparison between treatment groups at each time point was performed using the Fisher LSD test. Analyses were conducted using Statistica 10 for Windows (StatSoft.Inc, Tulsa, OK). Statistical significance was set at \<.05.

Results {#s0012}
=======

Participants' characteristics and safety {#s0013}
----------------------------------------

Twenty participants were randomised to the interventions. One person developed an ischaemic event during the physical exercise testing performed at the second visit and he was excluded from the study ([Figure 1](#F0001){ref-type="fig"}). The remaining 19 participants (mean age 64.7 ± 3.0 years) reported no side effects apart for the expected urine discolouration related to the excretion of beetroot juice pigment (beeturia). Baseline VO~2~ max of participants was 23.6 ± 5.8 ml/kg/min for men and 20.5 ± 2.8 ml/kg/min for women.

![Plasma and urinary nitrate after either 7-d consumption of nitrate-rich or nitrate-depleted beetroot juice. Data presented as mean ±1SE.](IIJF_A_1328666_F0001_B){#F0001}

Body weight, dietary intake and self-reported physical activity {#s0014}
---------------------------------------------------------------

Mean baseline BMI was 25.6 ± 3.4 kg/m^2^. Body weight did not change during the study in either groups (*p* = .51) ([Table S1](http://dx.doi.org/10.1080/09637486.2017.1328666) of the Online Supplementary Material). Changes in self-reported physical activity were again not different between the placebo and the NO~3~ ^-^ arms (*p* = .99) ([Table S1](http://dx.doi.org/10.1080/09637486.2017.1328666) of the Online Supplementary Material).

Resting clinic and daily blood pressure {#s0015}
---------------------------------------

Baseline resting systolic and diastolic BP were 127.4 ± 16.1 mmHg (range: 100.0--168.0 mmHg) and 76.2 ± 9.6 mmHg (range: 61.6--95.7 mmHg), respectively. Clinic systolic BP were not significant after NO~3~ ^-^ consumption compared to placebo (−5.05 ± 9.45 vs. −2.64 ± 9.04 mmHg, respectively, *p* = .42) ([Figure 2(A)](#F0002){ref-type="fig"}). Similarly, daily BP was not significant for both systolic (*p* = .75) and diastolic (*p* = .63) readings measured over the 7-d period ([Figure 2(B)](#F0002){ref-type="fig"}).

![Resting (Panel A) and daily (Panel B) systolic and diastolic blood pressure (BP) measured during a 1 week oral consumption (End) with either nitrate-rich or nitrate-depleted beetroot juice. Data presented as mean ± SEM. SBP: systolic blood pressure; DBP: diastolic blood pressure.](IIJF_A_1328666_F0002_B){#F0002}

Augmentation index {#s0016}
------------------

NO~3~ ^-^ consumption did not have a significant effect on AIx (*p* = .87, [Figure S3](http://dx.doi.org/10.1080/09637486.2017.1328666)).

Blood pressure and cardiac function during standardised exercise {#s0017}
----------------------------------------------------------------

NO~3~ ^-^ consumption did not influence systolic BP response (*p* = .92, [Figure 3(A)](#F0003){ref-type="fig"}) during exercise, whereas a non-significant trend for lower diastolic BP after NO~3~ ^-^  supplementation (*p* = .08, [Figure 3(B)](#F0003){ref-type="fig"}). Specifically, lower diastolic BP readings were recorded during moderate sub-maximal exercise intensities (work rate: 40 W, 60 W and 80 W). Dietary NO~3~ ^-^ consumption did not modify parameters of cardiac function (CO, HR, SV and CI) measured at rest, during exercise and post-exercise recovery ([Figure 4(A--D)](#F0004){ref-type="fig"}). In addition, 1 week dietary NO~3~ ^-^ consumption did not modify the association between CO and oxygen consumption (VO~2~) (nitrate, B ± SE = 6.04 ± 0.34, *R* ^2^ = 0.60, *p* \< .001; placebo, B ± SE = 6.68 ± 0.42, *R* ^2^ = 0.55, *p* \< .001) measured at different levels of exercise intensities ([Figure S4](http://dx.doi.org/10.1080/09637486.2017.1328666) of the Online [Supplementary Material](http://dx.doi.org/10.1080/09637486.2017.1328666)).

![Systolic (Panel A) and diastolic (Panel B) blood pressure (BP) at rest, during incremental exercise and post-exercise recovery after 1 week oral consumption with either nitrate-rich or nitrate-depleted beetroot juice. Data presented as mean ± SEM.](IIJF_A_1328666_F0003_C){#F0003}

![Heart rate (Panel A), stroke volume (Panel B), cardiac output (Panel C) and cardiac index (Panel D) at rest, during incremental exercise and post-exercise recovery after 1 week oral consumption with either nitrate-rich or nitrate-depleted beetroot juice. Data presented as mean ± SEM.](IIJF_A_1328666_F0004_B){#F0004}

Laboratory biomarkers {#s0018}
---------------------

Concentrations of nitrite plus nitrate (NO~2~ ^-^+NO~3~ ^-^, NO*~x~*) in plasma and urine increased after NO~3~ ^-^ consumption by 150 ± 77% and 979 ± 488% compared to placebo (−9 ± 33% and −13 ± 34%, respectively). NO~3~ ^-^ consumption did not modify concentrations of fasting glucose (*p* = .41), insulin (*p* = .95) and HOMA-IR (*p* = .88). NO~3~ ^-^ consumption also did not induce any changes in biomarkers of endothelial function (cGMP, endothelin-1, E-Selectin, P-Selectin, thrombomodulin and ICAM-3), inflammation (IL-6) and oxidative stress (3-NT) ([Table 1](#t0001){ref-type="table"}).

###### 

Changes in metabolic and vascular biomarkers before and after consumption with either nitrate-rich or nitrate-depleted (placebo) beetroot juice for 1 week.

                           Placebo           Inorganic nitrate                                       
  ------------------------ ----------------- ------------------- ----------------- ----------------- ------
  Glucose (mmol/l)         5.58 ± 0.61       5.46 ± 0.35         5.38 ± 0.45       5.43 ± 0.35       0.41
  Insulin (pmol/l)         34.80 ± 22.20     33.40 ± 19.20       35.32 ± 21.26     33.36 ± 15.45     0.95
  HOMA-IR                  1.47 ± 0.97       1.36 ± 0.70         1.41 ± 0.93       1.36 ± 0.81       0.88
  Interleukin-6 (pg/ml)    3.24 ± 7.24       3.08 ± 5.48         2.80 ± 5.66       3.13 ± 7.54       0.47
  cGMP (pmol/ml)           33.27 ± 13.71     35.01 ± 12.02       36.28 ± 13.33     33.90 ± 15.95     0.30
  Endothelin-1 (pmol/ml)   1.32 ± 0.02       1.37 ± 0.24         1.39 ± 0.28       1.39 ± 0.31       0.59
  E-Selectin (pg/ml)       25.26 ± 12.49     24.42 ± 13.18       29.37 ± 9.65      28.76 ± 8.66      0.96
  P-Selectin (pg/ml)       68.75 ± 33.30     62.94 ± 34.88       78.57 ± 24.77     81.98 ± 23.74     0.49
  Thrombomodulin (ng/ml)   12.92 ± 5.93      12.03 ± 6.37        15.18 ± 4.04      14.64 ± 3.87      0.89
  ICAM-3 (pg/ml)           5.80 ± 2.69       5.47 ± 2.97         6.67 ± 2.11       6.49 ± 2.28       0.89
  3-NT (ng/ml)             356.44 ± 360.03   294.24 ± 349.94     208.10 ± 259.54   216.01 ± 201.44   0.37

Data presented as mean ± SD. HOMA-IR: homeostatic model for the assessment of insulin resistance; cGMP: cyclic guanosine monophosphate; ICAM-3: intercellular adhesion molecule 3; 3-NT: 3 nitro-tyrosine.

Discussion {#s0019}
==========

This study does not support a beneficial effect in the short-term of dietary NO~3~ ^-^ ingestion on cardiac and peripheral vascular health in older healthy adults. In particular, a lack of effect was observed for BP and central haemodynamic responses measured both at rest and during increased metabolic demands. These physiological measurements were complemented by a panel of circulating biomarkers of metabolic control, oxidative stress and endothelial integrity. None of these measurements were altered by 1-week dietary NO~3~ ^-^ ingestion, which stimulate further discussion on uncovering the factors that may explain the lack of efficacy in older populations and the contrast with the more consistent beneficial effects observed in younger populations.

Extensive work has been conducted in the last decade to test the effects of dietary NO~3~ ^-^ on BP but, despite numerous trials, the evidence is still limited due to the small sample size and short duration of completed trials (Siervo et al. [@CIT0035]; Gee & Ahluwalia [@CIT0012]; Khatri et al. [@CIT0021]; Mills et al. [@CIT0027]). Further research is especially needed in older populations, although patients with comorbidities such as peripheral arterial disease or heart failure (HF) appear to receive greater health benefits from dietary NO~3~ ^-^ consumption (Kenjale et al. [@CIT0020]; Zamani et al. [@CIT0037]; Eggebeen et al. [@CIT0011]). However, DeVan et al. ([@CIT0009]) have recently reported that sodium nitrite supplementation was well-tolerated and improved endothelial function and lessens carotid artery stiffening in middle-aged and older adults. Conversely, our group has recently reported non-significant effects of dietary  NO~3~ ^-^ consumption on endothelial function and on 24-h ambulatory BP in older adults with and without type 2 diabetes (\>60 years) (Lara, Ogbonmwan, et al. 2015; Siervo et al. [@CIT0034]). These results have also recently been corroborated by Bondonno et al. who found no effect of 7-d dietary NO~3~ ^-^ consumption on home and 24-h ambulatory BP in patients with raised BP (age range: 30--70 years) (Bondonno et al. [@CIT0004], [@CIT0003]). However, Kapil et al. showed that a 4-week intervention in drug-naïve hypertensive subjects (age range: 18--85 years) significantly reduced clinic, home and 24-h ambulatory BP and improved endothelial function (Kapil et al. [@CIT0018]). The divergence of results is again part of the discussion around the effects of dietary NO~3~ ^-^ on health outcomes and priority is now being assigned to the identification of factors accounting for the mixed findings. These factors may include phenotypic characteristics (i.e. age, BMI, health status) of the populations, dose of dietary nitrate and duration of supplementation, study design, measurement protocols of BP an vascular health, type of cardiopulmonary fitness test protocols. The dynamic BP responses during exercise have been investigated in young, healthy populations (Bond et al. [@CIT0002]; Lee et al. [@CIT0024]) and in patients with COPD (Berry et al. [@CIT0001]) and HF (Coggan et al. [@CIT0006]; Coggan & Peterson [@CIT0007]; Eggebeen et al. [@CIT0011]). In healthy young populations, two studies reported a decline of sub-maximal systolic BP after acute (single dose) and short-term (15 d) dietary NO~3~ ^-^ consumption (Bond et al. [@CIT0002]; Lee et al. [@CIT0024]). In older COPD patients, dietary NO~3~ ^-^ decreased systolic BP at rest, whereas only diastolic BP showed a significant decline during 5 W pedalling and 75% of maximal work rate (Berry et al. [@CIT0001]). In patients with HF, acute dietary NO~3~ ^-^ did not improve BP responses during knee extension or cycle ergometry tests at sub-maximal and maximal efforts (Coggan & Peterson [@CIT0007]). However, 1 week of daily dosing with dietary NO~3~ ^-^ significantly improved submaximal BP in elderly patients with HF with preserved ejection fraction (Eggebeen et al. [@CIT0011]). Our study is the first trial to investigate resting and dynamic BP responses in older healthy adults and our results do not support a beneficial effect of dietary NO~3~ ^-^ on oxygen consumption (data not shown) as well as vascular responses during exercise. Precisely why there is a lack of response to dietary NO~3~ ^-^ in our study is not known, since we have supplemented subjects for 1 week and administered a NO~3~ ^-^ dose considerably higher compared to other studies (\>700 mg/d). The factors explaining these divergent age-dependent responses are still largely undetermined, which could potentially be related to a decline in the reducing capacity to convert NO~3~ ^-^ into NO~2~ ^-^ or sensitivity of cellular targets to NO.

In mice, NO~3~ ^-^ consumption has been shown to increase the expression of calcium handling proteins in the heart, resulting in increased cardiomyocyte calcium signalling and improved LV contractile function (Pironti et al. [@CIT0031]). These findings have provided preliminary support to the role of dietary NO~3~ ^-^ as a cardiac modulator, which have then been translated into clinical interventions in populations without and with impaired cardiac function. In healthy populations, acute dietary NO~3~ ^-^ consumption did not modify resting or sub-maximal CO (Bond et al. [@CIT0002]), whereas an improvement of CO and SV was observed after a 1-week dietary NO~3~ ^-^ consumption (Lee et al. [@CIT0024]). The only study testing the acute effects of dietary NO~3~ ^-^ on cardiac function in HF patients with preserved ejection fraction found greater reductions in systemic vascular resistance, aortic AIx and increased CO during exercise (Zamani et al. [@CIT0037]). We tested whether dietary NO~3~ ^-^ could minimise the age-related decline in myocardial contractility and ejection fraction, which could prompt compensatory myocardial cardiac hypertrophy (North & Sinclair [@CIT0029]). This enhances in the short-term CO but the long-term effect of LV hypertrophy is known as represents an important step in the development of HF and coronary syndromes (Gosse [@CIT0014]). Our scope was to evaluate whether dietary NO~3~ ^-^ could represent an effective and simple nutritional intervention that may minimise age-related changes in cardiac function and impact, from a primary prevention perspective, on the risk for HF. However, these preliminary results may not support the beneficial effects of dietary NO~3~ ^-^ on cardiac function in older healthy populations but, if confirmed in more robust trials, dietary NO~3~ ^-^ may still represent a promising nutritional strategy in patients with impaired cardiac function.

The small sample size and the short duration are important limitations of this trial and a cautious interpretation of the results is needed; nevertheless, our study is to date one of the longest trials testing the effects of dietary NO~3~ ^-^ on resting and exercise vascular responses in older participants. We did not assess daily dietary intake during the trial. However, participants were asked to maintain their habitual dietary intake during the study and the differences in nitrate intake between intervention and placebo groups were clearly demonstrated by the large differences in plasma and urinary nitrate concentrations. Plasma NO~2~ ^-^ concentrations were not measured since it was not possible due to logistic constraints to process the samples immediately after collection to minimise the immediate NO~2~ ^-^ degradation (half-life: ∼5 min). However, in previous studies testing the effects of dietary NO~3~ ^-^ consumption in older participants where plasma NO~2~ ^-^ concentration was measured, an increase in plasma NO~3~ ^-^ and NO*~x~* concentrations similar to the amount observed in this study occurred alongside a significant rise in plasma NO~2~ ^-^ concentrations (Gilchrist et al. [@CIT0013]). In addition, the measurement of NO*~x~* was critical to assess the compliance to the interventions as well as the attainment of a significant rise in plasma NO~3~ ^-^ to enable an increased NO generation via the NO non-enzymatic pathway. Finally, the limitations of bio-reactance for the assessment of cardiac haemodynamic profiles have to be taken into account for the interpretation of the results.

Testing the efficacy of dietary NO~3~ ^-^ consumption on cardiovascular health is an attractive research area due to the potential use of natural products to increase NO~3~ ^-^ intake and applicability in long-term dosing. However, this short-term intervention showed that dietary NO~3~ ^-^ consumption did not modify physiological and biochemical markers of vascular health in healthy older adults. However, these findings are preliminary and require corroboration in studies with longer duration and larger samples of healthy older individuals as well as in older patients with increased cardiovascular risk.
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